Microglial pannexin-1 channel activation is a spinal determinant of joint pain

Michael Mousseau, Nicole E. Burma, Kwan Yeop Lee, Heather Leduc‐Pessah, Charlie H.T. Kwok, Allison Reid, Melissa O’Brien, Boriss Sagalajev, Jo Anne Stratton, Natalya Patrick,

Science Advances · 2018 · 120 citations · 43 references

DOIFull text

Open access

Concepts

Abstract

panx suppressed the aberrant discharge of spinal laminae I-II neurons evoked by innocuous mechanical hindpaw stimulation in arthritic rats. Furthermore, mice with a microglia-specific genetic deletion of Panx1 were protected from developing mechanical allodynia. Treatment with probenecid, a clinically used broad-spectrum Panx1 blocker, resulted in a striking attenuation of MIA-induced mechanical allodynia and normalized responses in the dynamic weight-bearing test, without affecting acute nociception. Probenecid reversal of mechanical allodynia was also observed in rats 13 weeks after anterior cruciate ligament transection, a model of posttraumatic osteoarthritis. Thus, Panx1-targeted therapy is a new mechanistic approach for alleviating joint pain.

References

43